Inhibition of VEGFR2 prevents DMBA-induced mammary tumor formation
- 1 August 2004
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 84 (8) , 989-998
- https://doi.org/10.1038/labinvest.3700128
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Expression of Angiogenic Factors Is Upregulated in DMBA-Induced Rat Mammary PathologiesPathobiology, 2004
- The ‘angiogenic switch’ in the progression from Barrett's metaplasia to esophageal adenocarcinomaEuropean Journal of Surgical Oncology, 2003
- Expression of VEGF and its receptors by myeloma cellsLeukemia, 2003
- Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expressionKidney International, 2002
- Neuropilin-1 Participates in Wound AngiogenesisPublished by Elsevier ,2002
- Angiogenesis as a biomarker and target in cancer chemopreventionThe Lancet Oncology, 2001
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- Steady-state mRNA expression for growth factors in DMBA-induced rat mammary tumorsCancer Letters, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesionsBreast Cancer Research and Treatment, 1988